(Q50564115)
Statements
Early decline of the HCV core antigen can predict SVR in patients with HCV treated by Pegylated interferon plus ribavirin combination therapy. (English)
1 reference
Tatsuya Fujino
1 reference
Makoto Nakamuta
1 reference
Yoko Aoyagi
1 reference
Kunitaka Fukuizumi
1 reference
Ryosuke Takemoto
1 reference
Tsuyoshi Yoshimoto
1 reference
Toshihiko Miyahara
1 reference
Naohiko Harada
1 reference
Hironori Sakai
1 reference
Manabu Nakashima
1 reference
Munechika Enjoji
1 reference
1 February 2009
1 reference
10
1 reference
1
1 reference
21-25
1 reference
Identifiers
1 reference